韩秀珍
-
副教授
硕士生导师
- 性别：女
- 出生日期：1971-11-07
- 毕业院校：山东大学
- 学历：博士研究生毕业
- 学位：博士生
- 在职信息：在职
- 所在单位：药学院
- 入职时间： 2002-07-16
- 所属院系：
齐鲁医学院
,
药学院
,
药学院
,
药学院
- 联系方式：67234f87d005c4aebfb5be59d36a5bc714c73b283e2d6ab38e910604937d937cfdb612286b10924c6fef52d3e5c9677f604b6dc3562c3aa68acc185b59dca421845ff033422b0bb6c62633e2185e657e59a4daa00f30c638952824918ff5ed5fd1c887a9c1d48092449c90bb5683c53204baafcd0aef2c6474a8280d2d25af50
访问量：
-
[21]
韩秀珍 , 纪建波 and 纪建波.
低分子量肝素对白细胞黏附和黏附分子表达的影响.
《中国生化药物杂志》,
24,
179,
2003.
-
[22]
刘兆鹏 , 姜永莉 and 韩秀珍.
Synthesis and Evaluation of Trehalose-Based Compounds as Novel Inhibitors of Cancer Cell Migration and Invasion.
Chem Biol Drug Des,
86,
1017,
2015.
-
[23]
程艳娜 , 韩秀珍 and 韩秀珍.
Protective effects of flavonoid glycoside from Dracocephalum Rupestre Hance on doxorubicin-treated H9c2 cardiomyocytes.
第八届海峡两岸心血管科学研讨会,
2011.
-
[24]
程艳娜 , 刘兆鹏 , 韩秀珍 and 韩秀珍.
海藻糖衍生物的抗肿瘤侵袭转移作用.
中国药理学会第十一次全国大会学术会议,
2011.
-
[25]
程艳娜 , 韩秀珍 and 张倩云.
BENC-511, a novel PI3K inhibitor, suppresses metastasis of non-small cell lung cancer cells by modulating beta-catenin/ZEB1 regulatory loop.
Chemico-Biological Interactions,
294,
18,
2018.
-
[26]
韩秀珍 and 陈上.
Anti-neovascularization effects of DMBT in age-related macular degeneration by inhibition of VEGF secretion through ROS-dependent signaling pathway.
Molecular and Cellular Biochemistry,
448,
225,
2018.
-
[27]
韩秀珍 and 李安琪.
The roles and signaling pathways of prolyl-4-hydroxylase 2 in the tumor microenvironment.
Chemico-Biological Interactions,
303,
40,
2019.
-
[28]
韩秀珍 and 姚红.
Protective effects of luteolin-7-O-glucoside against starvation-induced injury through upregulation of autophagy in H9c2 Cells.
BIOSCIENCE TRENDS,
11,
557,
2017.
-
[29]
张宇 and 韩秀珍.
The roles of ZEB1 in tumorigenic progression and epigenetic modifications.
Biomed Pharmacother.,
110,
400,
2019.
-
[30]
李水仙 and 韩秀珍.
Inhibitory effects of compound DMBT on hypoxia-induced vasculogenic mimicry in human breast cancer.
Biomedicine & Pharmacotherapy,
96,
982,
2017.
-
[31]
韩秀珍 and 纪建波.
低分子量肝素对白细胞黏附和黏附分子表达的影响.
《中国生化药物杂志》,
24,
179,
2003.
-
[32]
韩秀珍 and 韩秀珍.
Protective effects of naringenin-7-O-glucoside on doxorubicin-induced apoptosis in H9C2 cells.
European Journal of Pharmacology,
2008.
-
[33]
韩秀珍 and 韩秀珍.
The hypoxia-related signaling pathways of vasculogenic mimicry in tumor treatment..
Biomedicine & Pharmacotherapy,
80,
127,
2016.
-
[34]
程艳娜 , 刘兆鹏 , 曲显俊 , 韩秀珍 and 唐琳琳.
Inhibition of angiogenesis and invasion by DMBT is mediated by downregulation of VEGF and MMP-9 through Akt pathway in MDA-MB-231 breast cancer cells.
Food and chemical toxicology,
56,
204,
2013.
-
[35]
韩秀珍 and 韩秀珍.
基于Wnt/？-catenin信号通路的结直肠癌研究进展.
生命的化学,
9,
175,
2016.
-
[36]
刘兆鹏 , 姜永莉 , 韩秀珍 and 唐龙骞.
Synthesis and structure–activity relationships studies of brartemicin analogs as anti-invasive agents.
J. Antibiotics,
66,
531,
2013.
-
[37]
韩秀珍 and 韩秀珍.
The urokinase plasminogen activator system in breast cancer invasion and metastasis.
Biomedicine＆Pharmacotherapy,
67,
179,
2013.
-
[38]
曲显俊 , 韩秀珍 and 韩秀珍.
Downregulation of the CXCR4/CXCL12 axis blocks the activation of the Wnt/β-catenin pathway in human colon cancer cells.
Biomedicine & Pharmacotherapy,
71,
46,
2015.
-
[39]
韩秀珍 and 韩秀珍.
Protection of Luteolin-7-O-Glucoside Against Doxorubicin-Induced Injury Through PTEN/Akt and ERK Pathway in H9c2 Cells..
Cardiovasc Toxicol,
2015.
-
[40]
韩秀珍 , 唐琳琳 , 程艳娜 and 刘兆鹏.
Inhibition of invasion and metastasis by DMBT, a novel trehalose derivative, through Akt/GSK-3beta/beta-catenin pathway in B16BL6 cells.
Chemico-Biological Interactions,
222,
7,
2014.
